Get the Stockscreener App
0.9049
1.67%
0.0149
After Hours:
.90
-0.0049
-0.54%
Elutia Inc stock is traded at $0.9049, with a volume of 393.88K.
It is up +1.67% in the last 24 hours and down -29.30% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$0.89
Open:
$0.8913
24h Volume:
393.88K
Relative Volume:
2.43
Market Cap:
$34.46M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.3664
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
+2.68%
1M Performance:
-29.30%
6M Performance:
-58.30%
1Y Performance:
-75.54%
1-Day Range:
$0.8816
$0.9846
1-Week Range:
$0.86
$0.9999
52-Week Range:
$0.85
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.9049 | 37.73M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Risk vs reward if holding onto Elutia Inc.Trade Analysis Report & Verified Stock Trade Ideas - newser.com
Chart overlay techniques for tracking Elutia Inc.Quarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Is Elutia Inc. stock a buy before product launchesJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
How Elutia Inc. stock performs in high volatility marketsWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
How Elutia Inc. stock responds to policy changesWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Relative strength of Elutia Inc. in sector analysisWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30% - simplywall.st
Elutia appoints medical tech veteran Guido Neels to board of directors - Investing.com Nigeria
Elutia Completes Sale of BioEnvelope to Boston Scientific - MSN
Applying big data sentiment scoring on Elutia Inc.Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Elutia Appoints Guido J. Neels To Board - citybiz
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - The Manila Times
Elutia Inc. Appoints Guido J. Neels to Board of Directors, Strengthening Leadership in Medical Technology - Quiver Quantitative
Elutia appoints accomplished medtech veteran Guido J. Neels to board of directors - MarketScreener
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors - TradingView
When is the best time to exit Elutia Inc.2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Backtesting results for Elutia Inc. trading strategies2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
What MACD signals say about Elutia Inc.2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Using portfolio simulators with Elutia Inc. includedMarket Growth Review & Detailed Earnings Play Strategies - newser.com
Combining machine learning predictions for Elutia Inc.Layoff News & Risk Controlled Stock Pick Alerts - newser.com
Tools to monitor Elutia Inc. recovery probabilityWatch List & High Accuracy Swing Entry Alerts - newser.com
Medical Device Innovator: Michelle LeRoux Williams - The Business Journals
SWK Holdings announces full repayment of Elutia loan following asset sale - Investing.com Canada
SWK Holdings announces full repayment of Elutia loan following asset sale By Investing.com - Investing.com Nigeria
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
SWK Holdings Announces Full Loan Repayment by Elutia - TipRanks
Elutia Closes BioEnvelope Business Sale To Boston Scientific For $88 Million - citybiz
Elutia announces closing of BioEnvelope business sale to Boston Scientific Corporation - MarketScreener
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - The Manila Times
Elutia Inc. Completes $88 Million Sale of BioEnvelope Business to Focus on NXT-41x Development for Breast Reconstruction - Quiver Quantitative
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Benzinga
$88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market - Stock Titan
Elutia (NASDAQ:ELUT) Stock Price Down 6.3% – Should You Sell? - Defense World
Will a bounce in Elutia Inc. offer an exit2025 Dividend Review & Community Consensus Trade Signals - newser.com
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elutia Inc Stock (ELUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):